487 related articles for article (PubMed ID: 6458230)
1. [Value and limitations of scintigraphy based on methylene diphosphonate pyrophosphate labeled with 99m technetium in the monitoring of revascularized bone transplants].
Clouet M; Chavoin JP; Vigoni F; Pessey JJ; Costagliola M
Ann Chir Plast; 1981; 26(3):217-20. PubMed ID: 6458230
[No Abstract] [Full Text] [Related]
2. The use of Tc-99m MDP bone scanning in the study of vascularized bone implants: concise communication.
Dee P; Lambruschi PG; Hiebert JM
J Nucl Med; 1981 Jun; 22(6):522-5. PubMed ID: 6453211
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
4. Bone scintigraphy in evaluating the viability of composite bone grafts revascularized by microvascular anastomoses, conventional autogenous bone grafts, and free non-revascularized periosteal grafts.
Berggren A; Weiland AJ; Ostrup LT
J Bone Joint Surg Am; 1982 Jul; 64(6):799-809. PubMed ID: 7045130
[TBL] [Abstract][Full Text] [Related]
5. [Bone scintigraphy with 99mTc-labeled methylene diphosphonate in hemodialysis patients (author's transl)].
Yamashita M; Aoki T; Kakiuchi T; Mabuchi H; Tabata Y; Murao Y; Nishizawa H; Maruyama Y; Kishi Y; Nakahashi H; Murakami K
Radioisotopes; 1981 Nov; 30(11):609-11. PubMed ID: 6461029
[No Abstract] [Full Text] [Related]
6. Bone scanning in assessing viability of vascularized skeletal tissue transplants.
Lipson RA; Dief H; Greyson ND; Kawano H; Gross AE; Langer F; Halloran PF
Clin Orthop Relat Res; 1981 Oct; (160):279-89. PubMed ID: 6456859
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
8. [Bone scintigraphy with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) (author's transl)].
Okahashi S; Ishimaru T; Maeda H; Sakata T; Yamasaki K; Akagi H
Radioisotopes; 1981 Aug; 30(8):458-60. PubMed ID: 7335921
[No Abstract] [Full Text] [Related]
9. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)].
Isobe Y; Ko S; Umegaki Y; Takahashi S; Kawaguchi N; Wada S; Matsumoto S
Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900
[No Abstract] [Full Text] [Related]
10. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
Tan KF; Chang CH
Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
[No Abstract] [Full Text] [Related]
11. Early dynamic bone-imaging as an indicator of osseous blood flow and factors affecting the uptake of 99mTc hydroxymethylene diphosphonate in healing bone.
Nutton RW; Fitzgerald RH; Kelly PJ
J Bone Joint Surg Am; 1985 Jun; 67(5):763-70. PubMed ID: 3997929
[TBL] [Abstract][Full Text] [Related]
12. Labeling efficiency and stomach concentration in methylene diphosphonate bone imaging.
Dhawan V; Yeh SD
J Nucl Med; 1979 Jul; 20(7):791-3. PubMed ID: 541718
[TBL] [Abstract][Full Text] [Related]
13. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
Armas R; Neumann R; Goldsmith SJ
J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of 99mTc-methylene diphosphonate scintigraphy of patients with lung cancer].
Abe M; Ohde R; Ogata T; Kawaguchi S; Kikuchi K; Kawai T; Matsuzawa K; Takanoshi H
Rinsho Hoshasen; 1982 Jun; 27(6):621-5. PubMed ID: 6292553
[No Abstract] [Full Text] [Related]
15. [An experimental crossover study between hydroxymethylene diphosphonate kit and methylene diphosphonate (author's transl)].
Nagai K; Muranaka A; Otsuka N; Terashima H; Yanagimoto S; Nagase N; Ito Y
Radioisotopes; 1982 Jan; 31(1):32-4. PubMed ID: 6461888
[No Abstract] [Full Text] [Related]
16. [Basic and clinical studies on bone deposition of 99mTc-labeled hydroxymethylene diphosphonate: a comparison with 99mTc-methylene diphosphonate (author's transl)].
Muranaka A; Ito Y; Otsuka N; Nagai K; Terashima H; Yanagimoto S; Kaji T; Nakano Y; Hayashi M; Hazue M
Kaku Igaku; 1981 Mar; 18(2):273-81. PubMed ID: 6454802
[No Abstract] [Full Text] [Related]
17. [Value of bone scintigraphy in secondary (intestinal) hyperparathyroidism].
Braun W; Heidenreich P; Guth H
Rofo; 1984 Apr; 140(4):457-63. PubMed ID: 6232181
[TBL] [Abstract][Full Text] [Related]
18. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
[TBL] [Abstract][Full Text] [Related]
19. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent].
Ishine M; Kawamura M; Koizumi M; Itoh H; Murase K; Inatsuki S; Iio A; Hamamoto K
Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr; 42(4):389-97. PubMed ID: 6214765
[No Abstract] [Full Text] [Related]
20. [Bone scintigraphy with Tc 99m MDP in the study of late complications of total hip prosthesis].
Tarozzi C; Furno A; Fagioli G; Arguello JM; Miglietta A; Specchia L; Ruggieri N; Rimondi E; De Benedittis M; Galletti S
Chir Organi Mov; 1984; 69(1):57-64. PubMed ID: 6237892
[No Abstract] [Full Text] [Related]
[Next] [New Search]
